|
⚲
|
| Keyboard |
| Sharma Panna
✚
|
|
|---|---|
| CIK # | 0001157989 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001157989] | |
| 4 | [0001157989] | |
| SC 13D | [0001157989] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Sharma Panna | Lantern Pharma Inc | [2020-06-19] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Lantern Pharma | |
| Sharma Panna | |
| Cancer Genetics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Lantern Pharma LTRN
Stock Option (Right to Buy) · derivative
|
2024-07-15 | Grant | 70,000 | $0.00 | |
|
Lantern Pharma LTRN
Stock Option (Right to Buy) · derivative
|
2022-08-06 | Grant | 100,000 | $0.00 | |
|
Lantern Pharma LTRN
Stock Option · derivative
|
2020-06-15 | Grant | 76,628 | ||
|
Cancer Genetics Inc CGIX
Stock Option (right to buy) · derivative
|
2017-02-22 | Grant | 200,000 | $0.00 | |
|
Cancer Genetics Inc CGIX
Common Stock, par value $0.0001 per share
|
2016-03-17 | Buy | 500 | $2.58 | 1,290 |
|
Cancer Genetics Inc CGIX
Common Stock, par value $0.0001 per share
|
2016-03-16 | Buy | 1,000 | $2.60 | 2,600 |
|
Cancer Genetics Inc CGIX
Common Stock, par value $0.0001 per share
|
2016-03-15 | Buy | 1,000 | $2.56 | 2,560 |
|
Cancer Genetics Inc CGIX
Stock Option (right to buy) · derivative
|
2014-12-11 | Grant | 250,000 | $0.00 | |
|
Cancer Genetics Inc CGIX
Common Stock, par value $0.0001 per share
|
2014-12-11 | Grant | 100,000 | $0.00 | |
|
Cancer Genetics Inc CGIX
Common Stock, par value $0.0001 per share
|
2014-05-22 | Grant | 50,000 | $0.00 | |
|
Cancer Genetics Inc CGIX
Stock Option (right to buy) · derivative
|
2013-10-10 | Grant | 200,000 | $0.00 |